Eptifibatide fumarate is an medication used to reduce thrombosis formation during cardiac interventions , like percutaneous coronary intervention (PCI) . It works as an glycoprotein IIb/IIIa receptor , blocking platelet aggregation – as a result lowering the chance of a cardiac event. This explan